Evidence map›Paper›PMID 31835389›Full record

ArticleInternational journal of molecular sciences2019

Development of Thiazolidinedione-Based HDAC6 Inhibitors to Overcome Methamphetamine Addiction.

Chiranjeev Sharma, Yong Jin Oh, Byoungduck Park, Sooyeun Lee, Chul-Ho Jeong, Sangkil Lee, Ji Hae Seo, Young Ho Seo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. An update: epigenetic mechanisms underlying methamphetamine addiction.Frontiers in cell and developmental biology · 2024
    Review
  2. Article
  3. Review
  4. HDAC6: A unique HDAC family member as a cancer target.Cellular oncology (Dordrecht, Netherlands) · 2022
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Chiranjeev SharmaCollege of Pharmacy, Keimyung University, Daegu 42601, Korea.
Yong Jin OhCollege of Pharmacy, Keimyung University, Daegu 42601, Korea.
Byoungduck ParkCollege of Pharmacy, Keimyung University, Daegu 42601, Korea.
Sooyeun LeeCollege of Pharmacy, Keimyung University, Daegu 42601, Korea.
Chul-Ho JeongCollege of Pharmacy, Keimyung University, Daegu 42601, Korea.
Sangkil LeeCollege of Pharmacy, Keimyung University, Daegu 42601, Korea.
Ji Hae SeoDepartment of Biochemistry, School of Medicine, Keimyung University, Daegu 42601, Korea.
Young Ho SeoCollege of Pharmacy, Keimyung University, Daegu 42601, Korea.
Keimyung University · KR

Funding

National Research Foundation of Korea (NRF) funded by the Ministry of Education NRF-2016R1A6A1A03011325National Research Foundation of Korea (NRF) funded by the Ministry of Education NRF-2016R1D1A1B01009559
6 · The paper itself

Abstract

Thiazolidinedione is a five-membered heterocycle that is widely used in drug discovery endeavors. In this study, we report the design, synthesis, and biological evaluation of a series of thiazolidinedione-based HDAC6 inhibitors. In particular, compound

Indexed as

Drug DiscoveryHistone Deacetylase InhibitorsThiazolidinedionesAmphetamine-Related DisordersCell Line, TumorHistone Deacetylase 6HumansIsoenzymesHDAC6 protein, humanHistone Deacetylase 6Histone Deacetylase InhibitorsIsoenzymesThiazolidinedionesdrug addictionHDAC6 inhibitorsmethamphetaminethiazolidinedione

Identifiers

PMID31835389
PMCPMC6940941
OpenAlexW2994515545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.